Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
The Journal of Pathology|October 11, 2002
Towards defining roles and relationships for tenascin-C and TGFbeta-1 in the normal and neoplastic urinary bladderCatherine Booth, Patricia Harnden, Peter J Selby, et al.
Molecular Biosystems|June 20, 2008
Mining the archival formalin-fixed paraffin-embedded tissue proteome: opportunities and challengesNiroshini J Nirmalan, Patricia Harnden, Peter J Selby, et al.
Journal of Clinical Pathology|January 11, 2011
A practical application of analysing weighted kappa for panels of experts and EQA schemes in pathologyKaren C Wright, Patricia Harnden, Sue Moss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotypeEmma J Chapman, Patricia Harnden, Philip Chambers, et al.
European Urology|July 8, 2008
Does the extent of carcinoma in prostatic biopsies predict prostate-specific antigen recurrence? A systematic reviewPatricia Harnden, Michael D Shelley, Brian Naylor, et al.
Cancer Letters|June 1, 2005
Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancerMargaret A Knowles, Joanne S Aveyard, Claire F Taylor, et al.
The American Journal of Pathology|March 14, 2002
Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitationsRachel A Craven, Nick Totty, Patricia Harnden, et al.
International Journal of Oncology|July 25, 2012
Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinomaClaire Taylor, Rachel A Craven, Patricia Harnden, et al.
Pageof 5